AMGN vs RAL · P/E 24, rev $36.75B vs rev $2.07B
Amgen Inc (AMGN) versus Ralliant Corporation Common Stock (RAL) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Ralliant Corporation Common Stock (RAL) is a electronic components company listed on NYSE.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported RAL revenue for 2025-12-31 was $2.07B. Net income was -$1.22B. Revenue was down 4.0% from 2024-12-31 to 2025-12-31. RAL currently screens at market cap $7.76B.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. RAL currently screens at market cap $7.76B.
Not investment advice. Open the AMGN and RAL stock pages for the full models.
Not investment advice.